BackCeryvyn Therapeutics Overview

Ceryvyn Therapeutics Current Assets

Latest current assets for CYV.AX: $24M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$23.72M
↓ 83.54% YoYΔ $-120.41M vs prior year quarter

Peer trimmed avg / median

Loading

Ceryvyn Therapeutics Current Assets History

Loading

Ceryvyn Therapeutics vs. peers: Current Assets Comparison

Loading

Ceryvyn Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ceryvyn Therapeutics (CYV.AX) FAQ

As of the most recent data (December 2025), CYV.AX shows a current assets of $24M. That compares with $140M in the prior-year period — down 83.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYV.AX's current assets is now $24M (was $140M) — a 83.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ceryvyn Therapeutics is outperforming or lagging.

Tracking CYV.AX's current assets over time shows whether Ceryvyn Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $24M That compares with $140M in the prior-year period — down 83.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Ceryvyn Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $24M) with ownership activity and broader fundamentals.

Ceryvyn Therapeutics's current assets is $24M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.